344 related articles for article (PubMed ID: 29550565)
21. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
[TBL] [Abstract][Full Text] [Related]
22. Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?
Seo JW; Park KB; Chin HM; Jun KH
PLoS One; 2023; 18(6):e0283366. PubMed ID: 37285389
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
[TBL] [Abstract][Full Text] [Related]
24. Correlation of microsatellite status and EBV infection with clinical characteristics of patients with gastric cancer.
Lu P; Yushan K; Yusufu G; Wang H; Mao R
Gen Physiol Biophys; 2023 Sep; 42(5):403-415. PubMed ID: 37702446
[TBL] [Abstract][Full Text] [Related]
25. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
26. CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers.
Kim K; Noh S; Cheong JH; Kim H
Gut Liver; 2021 Sep; 15(5):694-704. PubMed ID: 34312322
[TBL] [Abstract][Full Text] [Related]
27. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
[TBL] [Abstract][Full Text] [Related]
28. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
[TBL] [Abstract][Full Text] [Related]
29. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
[TBL] [Abstract][Full Text] [Related]
30. [Impact of the Epstein Barr virus on gastric cancer in Peru].
Beltrán Gárate B; Camara A; Kapsoli Sánchez MDC; Castro Uriol D; Yábar Berrocal A
Rev Gastroenterol Peru; 2019; 39(4):319-322. PubMed ID: 32097390
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study.
Muti HS; Heij LR; Keller G; Kohlruss M; Langer R; Dislich B; Cheong JH; Kim YW; Kim H; Kook MC; Cunningham D; Allum WH; Langley RE; Nankivell MG; Quirke P; Hayden JD; West NP; Irvine AJ; Yoshikawa T; Oshima T; Huss R; Grosser B; Roviello F; d'Ignazio A; Quaas A; Alakus H; Tan X; Pearson AT; Luedde T; Ebert MP; Jäger D; Trautwein C; Gaisa NT; Grabsch HI; Kather JN
Lancet Digit Health; 2021 Oct; 3(10):e654-e664. PubMed ID: 34417147
[TBL] [Abstract][Full Text] [Related]
32. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients.
Shen H; Zhong M; Wang W; Liao P; Yin X; Rotroff D; Knepper TC; Mcleod HL; Zhou C; Xie S; Li W; Xu B; He Y
Clin Chim Acta; 2017 Aug; 471():216-221. PubMed ID: 28601671
[TBL] [Abstract][Full Text] [Related]
33. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.
Kim HS; Shin SJ; Beom SH; Jung M; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Rha SY; Kim H
Oncotarget; 2016 Jul; 7(28):44608-44620. PubMed ID: 27331626
[TBL] [Abstract][Full Text] [Related]
35. Exploring the Genetic Diversity of Epstein-Barr Virus among Patients with Gastric Cancer in Southern Chile.
Reyes ME; Zanella L; Riquelme I; Buchegger K; Mora-Lagos B; Guzmán P; García P; Roa JC; Ili CG; Brebi P
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511034
[TBL] [Abstract][Full Text] [Related]
36. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F
Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.
Herath CH; Chetty R
Arch Pathol Lab Med; 2008 Apr; 132(4):706-9. PubMed ID: 18384225
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
39. EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas.
Park HY; Kang SY; Kang GH; Bae GE; Lee SE; Kim KM; Park CK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Oncol; 2012 Nov; 106(6):777-82. PubMed ID: 22513802
[TBL] [Abstract][Full Text] [Related]
40. Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Panda A; Mehnert JM; Hirshfield KM; Riedlinger G; Damare S; Saunders T; Kane M; Sokol L; Stein MN; Poplin E; Rodriguez-Rodriguez L; Silk AW; Aisner J; Chan N; Malhotra J; Frankel M; Kaufman HL; Ali S; Ross JS; White EP; Bhanot G; Ganesan S
J Natl Cancer Inst; 2018 Mar; 110(3):316-320. PubMed ID: 29155997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
